Childhood Cancer Predisposition Study (CCPS)
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT04511806
- Status
- Recruiting
Conditions
- Pediatric Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Registry — OTHERThis prospective registry and biorepository will collect clinical data and specimens for research in childhood cancer predisposition.
Study Details
The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at high risk for childhood cancer creates a unique opportunity for improving the understanding of carcinogenesis, tumor surveillance, early detection, and cancer prevention, which will collectively contribute to improving care and outcomes for pediatric patients with cancer and those with cancer predisposition syndromes (CPS).
Key Dates
- Start date
- Apr 22, 2021
- Status verified
- Oct 2025
- Primary completion
- Oct 31, 2030
- Completion
- Oct 31, 2030
Study Design
- Enrollment
- 1,050 participants (estimated)
Arms
- Arm: Primary SubjectsChildren (age 0-21) with a cancer predisposition syndromes (CPS).
- Arm: Relatives of Children with CPSMembers of their Primary Family Unit will also be recruited for this study, including CPS-Affected Parents, Unaffected Parents and Siblings. Other adult family members (with documented or obligate CPS) are also eligible to enroll as Affected Family Members.
Primary Outcome Measure
Establish and maintain a framework for recruitment, participation, and surveillance of children with cancer predisposition syndromes (CPS) in clinical and translational research studies. [ Time Frame: Up to 10 years ]
Central Contacts
- Christopher Porter, MD4047274881
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Healthcare of Atlanta (CHOA) | Atlanta | Georgia | 30322 | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Lisa Diller, MD |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Garrett Brodeur, MD |
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105-3678 | Kim Nichols, MD |
| Baylor College of Medicine | Houston | Texas | 77030 | Surya Rednam, MD |
| Primary Children's Hospital | Salt Lake City | Utah | 84113 | Joshua Schiffman, MD |
Find similar trials in Atlanta, GA
Related Studies
- Beat Childhood Cancer Specimen Banking and Data RegistryRecruiting · Giselle Sholler · Little Rock, Arkansas
- Targeted Therapy to Increase RAI Uptake in Metastatic DTCRecruiting · Children's Hospital of Philadelphia · San Francisco, California
- Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With CancerRecruiting · Nemours Children's Clinic · Los Angeles, California
- Response to Influenza Vaccination in Pediatric Oncology PatientsRecruiting · St. Jude Children's Research Hospital · Memphis, Tennessee